1. Home
  2. AIMD vs SYNX Comparison

AIMD vs SYNX Comparison

Compare AIMD & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • SYNX
  • Stock Information
  • Founded
  • AIMD 1984
  • SYNX 2005
  • Country
  • AIMD United States
  • SYNX Israel
  • Employees
  • AIMD N/A
  • SYNX N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • SYNX
  • Sector
  • AIMD Health Care
  • SYNX
  • Exchange
  • AIMD Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • AIMD 11.9M
  • SYNX 11.4M
  • IPO Year
  • AIMD N/A
  • SYNX 2024
  • Fundamental
  • Price
  • AIMD $2.86
  • SYNX $1.66
  • Analyst Decision
  • AIMD
  • SYNX
  • Analyst Count
  • AIMD 0
  • SYNX 0
  • Target Price
  • AIMD N/A
  • SYNX N/A
  • AVG Volume (30 Days)
  • AIMD 75.3K
  • SYNX 119.2K
  • Earning Date
  • AIMD 08-04-2025
  • SYNX 05-14-2025
  • Dividend Yield
  • AIMD N/A
  • SYNX N/A
  • EPS Growth
  • AIMD N/A
  • SYNX N/A
  • EPS
  • AIMD N/A
  • SYNX N/A
  • Revenue
  • AIMD $106,207.00
  • SYNX $9,094,000.00
  • Revenue This Year
  • AIMD N/A
  • SYNX $32.35
  • Revenue Next Year
  • AIMD N/A
  • SYNX N/A
  • P/E Ratio
  • AIMD N/A
  • SYNX N/A
  • Revenue Growth
  • AIMD 13.38
  • SYNX 19.14
  • 52 Week Low
  • AIMD $2.00
  • SYNX $1.52
  • 52 Week High
  • AIMD $5.00
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 48.86
  • SYNX 38.43
  • Support Level
  • AIMD $3.07
  • SYNX $1.52
  • Resistance Level
  • AIMD $3.34
  • SYNX $1.71
  • Average True Range (ATR)
  • AIMD 0.24
  • SYNX 0.10
  • MACD
  • AIMD 0.01
  • SYNX -0.01
  • Stochastic Oscillator
  • AIMD 54.84
  • SYNX 12.44

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: